MED11

MED11 is an essential subunit of the Mediator head module that couples transcriptional activator signals to the assembly of the RNA polymerase II preinitiation complex (PMID:9812975, PMID:18691966). Within the head module, MED11 (Med11) and Med22 form a conserved four-helix bundle heterodimer whose C-terminal extensions bind the central head subunit Med17, anchoring it within the neck submodule of the head (PMID:21498544, PMID:23123849). A highly conserved surface patch on this bundle directly engages the TFIIH subunit Rad3 and is required for stable PIC formation; disrupting the Med11-Rad3 interaction impairs recruitment of TFIIH, TFIIE, and Pol II, and reduces genome-wide Pol II CTD serine 5 phosphorylation (PMID:18691966, PMID:21498544). Genetic loss of MED11 produces activator-specific transcriptional defects rather than a global shutdown, consistent with a role in conveying particular activation signals (PMID:9891034). Human MED11 is required for Tat-dependent transcription of HIV-1 at a post-integration step (PMID:25100719), and a homozygous truncating variant (p.Arg109Ter) that disrupts the MED11 C-terminus causes a lethal neurodegenerative disease, with a zebrafish knockout recapitulating key phenotypes (PMID:36001086).

1. 1998 Medium

   Established that MED11 is a genuine constituent of the Mediator/Pol II holoenzyme rather than a loosely associated factor, defining it as part of the core transcription machinery.

   Evidence Copurification and reciprocal co-immunoprecipitation with Pol II holoenzyme plus peptide sequencing in yeast

   PMID:9812975

   Open questions at the time

   • Did not localize MED11 to a specific Mediator module
   • No functional role assigned
2. 1999 Medium

   Showed that MED11 carries an activator-specific function, distinguishing it from subunits required for general transcription and implying gene-selective regulatory output.

   Evidence Differential display and Northern analysis of Mediator-mutant yeast revealing a specific MFalpha1 activation defect

   PMID:9891034

   Open questions at the time

   • Mechanism linking MED11 to specific activators unknown
   • No direct partner mapping
3. 2003 Medium

   Extended MED11's identity as a bona fide Mediator subunit to mammals and began mapping its direct pairwise contacts within the complex.

   Evidence Tandem mass spectrometry of Med8-containing fractions and direct biochemical binding assays

   PMID:12584197

   Open questions at the time

   • Specific binding partners and module assignment not fully resolved
   • No functional consequence tested in mammals
4. 2008 High

   Defined the mechanistic core of MED11 function: a direct head-module contact with the TFIIH subunit Rad3 that drives recruitment of TFIIH, TFIIE, and Pol II and supports CTD serine 5 phosphorylation.

   Evidence Genome-wide ChIP, genetic interaction analysis, and Pol II CTD phosphorylation assays in yeast med11 mutants

   PMID:18691966

   Open questions at the time

   • Structural basis of the Med11-Rad3 interface not resolved here
   • Whether interaction is direct vs bridged not fully distinguished
5. 2011 High

   Resolved the architecture of MED11 as a four-helix bundle heterodimer with Med22 anchored to Med17, and identified a conserved surface patch essential for PIC formation.

   Evidence Structure-function analysis with in vitro PIC reconstitution and in vivo mutant validation in yeast

   PMID:21498544

   Open questions at the time

   • Direct atomic-resolution contact with TFIIH not visualized
   • Patch's precise recruitment partner inferred, not co-crystallized
6. 2012 High

   Placed MED11 in the high-resolution head-module structure within the neck submodule helical spine, contextualizing its position relative to Pol II and CTD-interacting elements.

   Evidence X-ray crystallography of the S. pombe Mediator head at 3.4 Å with in vitro transcription validation

   PMID:23123849

   Open questions at the time

   • Structure is of the isolated head, not the full PIC
   • Dynamic conformational changes during recruitment not captured
7. 2014 Medium

   Demonstrated a host-factor role for human MED11 in Tat-dependent HIV-1 transcription, extending its Pol II transcription function to a pathogen-relevant context.

   Evidence siRNA knockdown with RT-PCR of early HIV transcripts and viral replication assays in human cells

   PMID:25100719

   Open questions at the time

   • Whether effect is direct or via global Mediator function unclear
   • No mapping of MED11 contacts to the TAR/Tat machinery
8. 2022 Medium

   Linked MED11 to human Mendelian disease, showing that a C-terminal truncation rather than protein loss underlies a lethal neurodegenerative phenotype consistent with impaired Mediator assembly.

   Evidence Patient fibroblast western blot/RT-PCR plus CRISPR zebrafish knockout and exome/genome sequencing

   PMID:36001086

   Open questions at the time

   • Direct demonstration of impaired subunit binding for the truncation not shown
   • Tissue-specific basis of neurodegeneration unexplained

• How MED11's conserved surface patch contacts TFIIH at atomic resolution within an assembled human PIC, and why its disruption produces selective neurodegeneration, remain unresolved.
• No structure of the MED11-TFIIH interface in a complete human PIC
• Mechanistic link between truncation and tissue-specific disease unknown